phenylalanine has been researched along with Eosinophilia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Álvarez de la Campa, E; Colobran, R; de la Cruz, X; Martín-Nalda, A; Martínez-Gallo, M; Pujol-Borrell, R; Soler-Palacín, P | 1 |
| Abe, T; Mori, T; Nagai, Y; Nomura, G | 1 |
2 other study(ies) available for phenylalanine and Eosinophilia
| Article | Year |
|---|---|
Clinical and structural impact of mutations affecting the residue Phe367 of FOXP3 in patients with IPEX syndrome.
Topics: Diabetes Mellitus, Type 1; Diarrhea; Dimerization; Eczema; Eosinophilia; Fatal Outcome; Forkhead Transcription Factors; Genetic Diseases, X-Linked; Growth Disorders; Hemorrhage; Hepatomegaly; Humans; Hydrophobic and Hydrophilic Interactions; Immune System Diseases; Immunoglobulin E; Infant; Klebsiella Infections; Leukocytosis; Lung Diseases; Male; Meningoencephalitis; Models, Molecular; Mutation; Phenylalanine; Sepsis; Splenomegaly; Thrombocytopenia; Thymus Gland | 2016 |
Immediate-Type allergy against human insulin associated with marked eosinophilia in type 2 diabetic patient.
Topics: Aged; Aged, 80 and over; Cyclohexanes; Diabetes Mellitus, Type 2; Drug Hypersensitivity; Eosinophilia; Erythema; Humans; Hypersensitivity, Immediate; Hypoglycemic Agents; Immunoglobulin E; Insulin; Male; Nateglinide; Phenylalanine; Seasons; Skin Tests | 2001 |